317 related articles for article (PubMed ID: 28095156)
1. Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study.
Muller DC; Johansson M; Brennan P
J Clin Oncol; 2017 Mar; 35(8):861-869. PubMed ID: 28095156
[TBL] [Abstract][Full Text] [Related]
2. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population.
Lyu Z; Li N; Chen S; Wang G; Tan F; Feng X; Li X; Wen Y; Yang Z; Wang Y; Li J; Chen H; Lin C; Ren J; Shi J; Wu S; Dai M; He J
Cancer Med; 2020 Jun; 9(11):3983-3994. PubMed ID: 32253829
[TBL] [Abstract][Full Text] [Related]
4. LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence.
Marcus MW; Chen Y; Raji OY; Duffy SW; Field JK
Cancer Prev Res (Phila); 2015 Jun; 8(6):570-5. PubMed ID: 25873368
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
[TBL] [Abstract][Full Text] [Related]
6. Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort.
Warkentin MT; Lam S; Hung RJ
EBioMedicine; 2019 Sep; 47():58-64. PubMed ID: 31495719
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a Risk Prediction Model for Lung Cancer Based on Lifestyle Behaviors in the UK Biobank Large-Scale Population Cohort].
Chen R; Wang J; Wang S; Tang S; Suo C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):892-898. PubMed ID: 37866943
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer screening CT-based prediction of cardiovascular events.
Mets OM; Vliegenthart R; Gondrie MJ; Viergever MA; Oudkerk M; de Koning HJ; Mali WP; Prokop M; van Klaveren RJ; van der Graaf Y; Buckens CF; Zanen P; Lammers JW; Groen HJ; Isgum I; de Jong PA
JACC Cardiovasc Imaging; 2013 Aug; 6(8):899-907. PubMed ID: 23769488
[TBL] [Abstract][Full Text] [Related]
9. 10-year performance of four models of breast cancer risk: a validation study.
Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
[TBL] [Abstract][Full Text] [Related]
10. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study.
Ganna A; Ingelsson E
Lancet; 2015 Aug; 386(9993):533-40. PubMed ID: 26049253
[TBL] [Abstract][Full Text] [Related]
11. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
[TBL] [Abstract][Full Text] [Related]
12. Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study.
Tang R; Fraser A; Magnus MC
BMJ Open; 2019 Oct; 9(10):e030318. PubMed ID: 31662371
[TBL] [Abstract][Full Text] [Related]
13. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
[TBL] [Abstract][Full Text] [Related]
14. The value of blood-based measures of liver function and urate in lung cancer risk prediction: A cohort study and health economic analysis.
Horsfall LJ; Clarke CS; Nazareth I; Ambler G
Cancer Epidemiol; 2023 Jun; 84():102354. PubMed ID: 36989955
[TBL] [Abstract][Full Text] [Related]
15. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
[TBL] [Abstract][Full Text] [Related]
16. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
[TBL] [Abstract][Full Text] [Related]
17. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
18. Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study.
Charvat H; Sasazuki S; Shimazu T; Budhathoki S; Inoue M; Iwasaki M; Sawada N; Yamaji T; Tsugane S;
Cancer Sci; 2018 Mar; 109(3):854-862. PubMed ID: 29345859
[TBL] [Abstract][Full Text] [Related]
19. An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population.
Chen W; Sin DD; FitzGerald JM; Safari A; Adibi A; Sadatsafavi M
Chest; 2020 Mar; 157(3):547-557. PubMed ID: 31542453
[TBL] [Abstract][Full Text] [Related]
20. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
